BIOMEDICAL DIAGNOSTICS
ActiveSummary
BIOMEDICAL DIAGNOSTICS has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.5m and a net result of €339,858. Equity is growing by about 18% per year across the filed financial years. Its solvency ranks better than 76% of 6,131 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Directors
Board 1
Day-to-day management 1
Permanent representatives 1
Statutory auditor 1
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- Day-to-day management
- Statutory auditor
- began earlier
| Name | Functions and periods |
|---|---|
| Olivier Bosc |
|
| STEENS MANAGEMENT |
|
| BV VAN HAVERMAET BEDRIJFSREVISOREN |
|
| NV Eurobio Scientific Benelux |
|
Owners and capital
Owners
2 ownersChain of control
- Eurobio Scientific SAFR
- EUROBIO SCIENTIFIC BENELUX
- BIOMEDICAL DIAGNOSTICS
Highest known parent: Eurobio Scientific SA (France). The sources do not say who stands above it.
Owners 2
- 100%
- Eurobio Scientific SAFRconsolidating parentconsolidates
Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
- Eurobio Scientific Benelux (BE 0424.732.712) all shares
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.